We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.25M
1-Year Est. Return 26.51%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
-26.51%
3 Year Est. Return
-47.48%
5 Year Est. Return
-89.34%
10 Year Est. Return
–
AUM
$1.49M
AUM Growth
+$33.1K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
18.7 quarters
Top 10 Avg Time Held
18.7 quarters
Top 20 Avg Time Held
18.7 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TCRX icon
1
TScan Therapeutics
TCRX
$16.1M
$630K 42.4%
630,000
– –
2021 Q3
18 quarters
HOWL icon
2
Werewolf Therapeutics
HOWL
$47.6M
$490K 33.01%
589,102
– –
2021 Q2
19 quarters
BRNS
3
DELISTED
Barinthus Biotherapeutics
BRNS
$365K 24.59%
642,204
– –
2021 Q2
19 quarters

Similar funds

DC Funds's Q1 2026 Portfolio in Review

As of Q1 2026, DC Funds held 3 positions worth $1.49M, up 2.3% from $1.45M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $1.49M portfolio in Q1 2026.
  • DC Funds opened 0 new positions and closed 0 in Q1 2026.
  • DC Funds's portfolio value rose 2.3% quarter-over-quarter to $1.49M.

Based on DC Funds's 13F filing for Q1 2026, filed 14 May 2026.